Rezolute, Inc. (RZLT) has 20 known insider and institutional holders on record. The largest holder is Genexine Inc. with 91,300,933 shares. Other notable holders include XOMA Corp and Huh Hoyoung.
Over the last 12 months, insiders have made 33 transactions in RZLT stock — 29 buys (valued at $8.8M) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
RZLT Insider Ownership
Top Holder
Genexine Inc.
91,300,933 shares
Buys (12 mo)
29
$8.8M value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Genexine Inc. |
10 Percent Owner |
91,300,933 |
2021-07-28 |
|
| 2 |
Xoma Corp |
10 Percent Owner |
8,093,010 |
2018-04-30 |
|
| 3 |
Huh Hoyoung |
Chairman, Scientific Adv. Bd. |
4,000,000 |
2017-01-18 |
|
| 4 |
Mantripragada Sankaram |
Chief Scientific Officer |
3,500,000 |
2019-09-16 |
|
| 5 |
Vendola Keith A. |
Chief Financial Officer |
3,000,000 |
2019-09-16 |
|
| 6 |
Handok, Inc. |
10 Percent Owner |
2,784,722 |
2024-03-19 |
|
| 7 |
Welch David F |
Director |
1,801,415 |
2017-03-15 |
|
| 8 |
Kukekov Nickolay |
Director |
1,597,074 |
2013-02-08 |
|
| 9 |
Sung Young Chul |
Director |
1,250,000 |
2019-03-08 |
|
| 10 |
Howe Steve |
Director |
1,125,000 |
2014-05-02 |
|
| 11 |
Kaeyo Investments Ltd |
10 Percent Owner |
893,750 |
2012-06-13 |
|
| 12 |
Chu Jue Min |
10 Percent Owner |
893,750 |
2012-06-13 |
|
| 13 |
Wolkin Orit |
10 Percent Owner |
893,750 |
2012-06-13 |
|
| 14 |
Elam Nevan C |
CEO |
613,501 |
2026-03-04 |
|
| 15 |
Fields Morgan |
Chief Accounting Officer |
600,000 |
2017-01-13 |
|
| 16 |
Evans Daron |
CFO |
414,462 |
2026-03-31 |
|
| 17 |
Sherman Barry Michael |
Director |
300,000 |
2017-01-13 |
|
| 18 |
Roberts Brian Kenneth |
Chief Medical Officer |
296,913 |
2026-03-04 |
|
| 19 |
Konus Advisory Group, Inc. |
10 Percent Owner |
234,700 |
2014-04-09 |
|
| 20 |
Hogenhuis Wladimir |
Director |
119,675 |
2025-12-17 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-03-30 |
Evans Daron |
CFO |
Informative Buy |
10,000 |
$2.85 |
$28.5K |
| 2026-03-02 |
Roberts Brian Kenneth |
Chief Medical Officer |
Tax Withholding of RSU |
11,439 |
$2.99 |
$34.2K |
| 2026-03-02 |
Evans Daron |
CFO |
Tax Withholding of RSU |
11,438 |
$2.99 |
$34.2K |
| 2026-03-02 |
Elam Nevan C |
CEO |
Tax Withholding of RSU |
27,618 |
$2.99 |
$82.58K |
| 2025-12-16 |
Roberts Brian Kenneth |
Chief Medical Officer |
Informative Buy |
28,000 |
$1.70 |
$47.6K |
| 2025-12-16 |
Hogenhuis Wladimir |
Director |
Informative Buy |
5,650 |
$1.69 |
$9.55K |
| 2025-12-15 |
Karnawat Sunil Ratilal |
Chief Commercial Officer |
Informative Buy |
12,000 |
$1.62 |
$19.44K |
| 2025-12-15 |
Evans Daron |
CFO |
Informative Buy |
2,500 |
$1.79 |
$4.46K |
| 2025-12-15 |
Elam Nevan C |
CEO |
Informative Buy |
32,000 |
$1.59 |
$50.88K |
| 2025-11-19 |
Karnawat Sunil Ratilal |
Chief Commercial Officer |
RSU Award |
19,000 |
$10.16 |
$193.04K |
| 2025-11-19 |
Roberts Brian Kenneth |
Chief Medical Officer |
Acquisition |
72,000 |
$10.16 |
$731.52K |
| 2025-11-19 |
Fauchet Philippe |
Director |
RSU Award |
12,000 |
$10.16 |
$121.92K |
| 2025-11-19 |
Harris Erik |
Director |
RSU Award |
12,000 |
$10.16 |
$121.92K |
| 2025-11-19 |
Kim Young-jin |
Director |
RSU Award |
12,000 |
$10.16 |
$121.92K |
| 2025-11-19 |
Hogenhuis Wladimir |
Director |
RSU Award |
12,000 |
$10.16 |
$121.92K |
| 2025-11-19 |
Kreher Nerissa |
Director |
RSU Award |
12,000 |
$10.16 |
$121.92K |
| 2025-11-19 |
Evans Daron |
CFO |
RSU Award |
63,000 |
$10.16 |
$640.08K |
| 2025-11-19 |
Labrucherie Gil M |
Director |
RSU Award |
12,000 |
$10.16 |
$121.92K |
| 2025-11-19 |
Elam Nevan C |
CEO |
RSU Award |
186,000 |
$10.16 |
$1.89M |
| 2025-08-18 |
Karnawat Sunil Ratilal |
Chief Commercial Officer |
RSU Award |
25,000 |
- |
- |
| 2025-08-18 |
Karnawat Sunil Ratilal |
Chief Commercial Officer |
Unknown |
- |
- |
- |
| 2025-06-25 |
Roberts Brian Kenneth |
Chief Medical Officer |
Informative Buy |
2,500 |
$4.38 |
$10.94K |
| 2025-06-24 |
Evans Daron |
CFO |
Informative Buy |
5,000 |
$4.05 |
$20.25K |
| 2025-06-13 |
Kim Young-jin |
Director |
Informative Buy |
1,230,769 |
$3.25 |
$4M |
| 2025-06-13 |
Kreher Nerissa |
Director |
Informative Buy |
3,076 |
$3.25 |
$10K |
